Cytomegalovirus infection as a predictor of preterm delivery: A retrospective analysis
DOI:
https://doi.org/10.37800/RM.4.2025.631Keywords:
cytomegalovirus infection (CMVI), pregnancy, preterm deliveryAbstract
Relevance: Preterm delivery is one of the major causes of perinatal complications and neonatal mortality. Among multiple risk factors, infectious and inflammatory processes — including viral infections that can disrupt placental blood flow and induce inflammation of the fetal membranes — play a key role. Cytomegalovirus infection (CMVI) is highly prevalent among women of reproductive age and often manifests in a latent form, making timely detection challenging. Previous or reactivated CMVI may impair placental hemorheology, trigger inflammatory cytokine activation, and provoke premature uterine contractions. Investigating the effect of prior CMV infection on preterm delivery risk is essential for early identification of high-risk groups and for developing preventive strategies to reduceadverse pregnancy outcomes.
The study aimed to assess the impact of cytomegalovirus infection as a predictor of preterm delivery.
Materials and Methods: This retrospective analysis involved 273 pregnant women treated at City Hospital No. 1 of Karaganda, Kazakhstan, in 2023-2024. The participants were divided into the Main group, comprising women with confirmed CMVI (ELISA and PCR), and the Control group, comprising women with negative CMVI results (ELISA and PCR).
Results: Preterm delivery occurred in 69.7% of women with prior CMVI and in 3.3% of controls. Risk indicators demonstrated a strong association (RR ≈ 20.9; OR ≈ 66.6; RD = 66.4%). Statistical significance was confirmed (p < 0.001; df = 1; χ² = 134.0). Potential mechanisms include placental and myometrial inflammation, impaired placental perfusion, and immune alterations following latent infection.
Conclusion: Previous cytomegalovirus infection represents a significant risk factor for preterm delivery. Women with positive preconception CMVI tests have a markedly increased likelihood of early delivery, contributing to adverse maternal and neonatal outcomes. These findings highlight the need for enhanced monitoring during pregnancy and increased vigilance among primary care physicians, particularly in late gestation.
References
1. Carmona AS, Kakkar F, Gantt S. Perinatal Cytomegalovirus Infection. Curr Treat Options Pediatr. 2022; 8(4):395-411
https://doi.org/10.1007/s40746-022-00261-y
2. Njue A, Coyne C, Margulis AV, Wang D, Marks MA, Russell K, Das R, Sinha A. The Role of Congenital Cytomegalovirus Infection in Adverse Birth Outcomes: A Review of the Potential Mechanisms. Viruses. 2020;13(1):20
https://doi.org/10.3390/v13010020
3. Kita H, Maeda K, Nukada T, Ikeda Y, Mamada M. Symptomatic Congenital Cytomegalovirus Infection in a Preterm Very-Low-Birth-Weight Infant Treated With Intravenous Ganciclovir Followed by Oral Valganciclovir. Cureus. 2025;17 (9):e92581.
https://doi.org/10.7759/cureus.92581
4. Mendez-Figueroa H, Hoffman MK, Grantz KL, Blackwell SC, Reddy UM, Chauhan SP. Shoulder dystocia and composite adverse outcomes for the maternal-neonatal dyad. Am J Obstet Gynecol MFM. 2021;3(4):100359.
https://doi.org/10.1016/j.ajogmf.2021.100359
5. Tayzhanova D, Rustembekkyzy Z, Komlichenko E, Ponamaryova O, Zhanabayeva S. Association of inflammatory mediators and molecular markers of iron metabolism in pregnancies with pregestational obesity during the development of anaemia: a narrative review. Italian J Obstet Gynaecol. 2024:36(3):272-280.
https://doi.org/10.36129/jog.2023.137
6. Rybak-Krzyszkowska M, Górecka J, Huras H, Massalska-Wolska M, Staśkiewicz M, Gach A, Kondracka A, Staniczek J, Górczewski W, Borowski D, Jaczyńska R, Grzesiak M, Krzeszowski W. Cytomegalovirus Infection in Pregnancy Prevention and Treatment Options: A Systematic Review and Meta-Analysis. Viruses. 2023;15(11):2142.
https://doi.org/10.3390/v15112142
7. Patel Choodinatha HK, Jeon MR, Choi BY, Lee KN, Kim HJ, Park JY. Cytomegalovirus infection during pregnancy. Obstet Gynecol Sci. 2023;66(6):463-476.
https://doi.org/10.5468/ogs.23117
8. Pontes KFM, Nardozza LMM, Peixoto AB, Werner H, Tonni G, Granese R, Araujo Júnior E. Cytomegalovirus and Pregnancy: A Narrative Review. J Clin Med. 2024;13(2):640.
https://doi.org/10.3390/jcm13020640
9. Pinninti S, Boppana S. Congenital cytomegalovirus infection diagnostics and management. Curr Opin Infect Dis. 2022;35(5):436-441.
https://doi.org/10.1097/QCO.0000000000000874
10. Омертаева Д., Мугазов М., Вазенмиллер Д., Шыхалиева К., Кайбасова А. Влияние показателей среднего объема тромбоцитов, среднего объема эритроцитов и гемоглобина на риск развития тяжелой преэклампсии у беременных женщин. Репродуктивная медицина (Центральная Азия). 2024;4:75-80. [Omertayeva D, Mugazov M, Vazenmiller D, Shykhaliyeva K, Kaibassova A. Mean platelet volume, corpuscular volume, and hemoglobin levels impact the risk of severe preeclampsia in pregnancy. Reproductive Medicine (Central Asia). 2024;4:75-80. In Russian].
https://doi.org/10.37800/RM.4.2024.412
11. Rouse DJ, MacPherson C, Saade GR, Dinsmoor MJ, Reddy UM, Pass R, Allard D, Mallett G, Clifton RG, Gyamfi-Bannerman C, Varner MW, Goodnight WH, Tita ATN, Costantine MM, Swamy GK, Heyborne KD, Chien EK, Chauhan SP, El-Sayed YY, Casey BM, Parry S, Simhan HN, Napolitano PG, Macones GA, Hughes BL; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. The association of cytomegalovirus hyperimmune globulin with adverse pregnancy outcomes. Am J Obstet Gynecol. 2025;233(2):e39-e42.
https://doi.org/10.1016/j.ajog.2025.04.014
12. Plotogea M, Isam AJ, Frincu F, Zgura A, Bacinschi X, Sandru F, Duta S, Petca RC, Edu A. An Overview of Cytomegalovirus Infection in Pregnancy. Diagnostics (Basel). 2022;12(10):24-29.
https://doi.org/10.3390/diagnostics12102429
13. Njue A, Coyne C, Margulis AV, Wang D, Marks MA, Russell K, Das R, Sinha A. The Role of Congenital Cytomegalovirus Infection in Adverse Birth Outcomes: A Review of the Potential Mechanisms. Viruses. 2020; 13(1): 20.
https://doi.org/10.3390/v13010020.
14. Begnel ER, Drake AL, Kinuthia J, Matemo D, Huang ML, Ásbjörnsdóttir KH, Chohan V, Beima-Sofie K, John-Stewart G, Lehman D, Slyker J. Cervical cytomegalovirus reactivation, cytokines and spontaneous preterm birth in Kenyan women. Clin Exp Immunol. 2021; 203(3):472-479.
https://doi.org/10.1111/cei.13558
15. Balegamire SJ, Mâsse B, Audibert F, Lamarre V, Giguere Y, Forest JC, Boucoiran I. Association Between Maternal Cytomegalovirus Seropositivity, Preterm Birth, and Preeclampsia in Two Cohorts From Quebec, Canada: A Mediation Analysis. Am J Reprod Immunol. 2024 ; 92(4): e13941.
https://doi.org/10.1111/aji.13941.
16. Liu Y, Wu Y, Wang F, Wang S, Zhao W, Chen L, Tu S, Qian Y, Liao Y, Huang Y, Zhang R, Xu G, Zhang D. The Association Between Previous TORCH Infections and Pregnancy and Neonatal Outcomes in IVF/ICSI-ET: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2020; 11:466.
https://doi.org/10.3389/fendo.2020.00466.
17. Al-Hakami AM, Paul E, Al-Abed F, Alzoani AA, Shati AA, Assiri MI, Qasim AA, Riaz F, Moosa RA, Chandramoorthy HC. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia. Saudi Med J. 2020;41(7): 757-762.
https://doi.org/10.15537/smj.2020.7.25121.
18. Zhang L, Lv W, Ya J, Li Y, Yuan D, Cai P, Chen L, Tang N, Chen H, Liu B, Tang X, Lai Q, Cheng G, Zhang L, Wei X, Zhong Q. Clinical characteristics, pregnancy outcomes, and neonatal effects of cytomegalovirus infection in pregnant women in Liuzhou city, North central Guangxi of Southern China: a retrospective study from 2018 to 2024. BMC Pregnancy Childbirth. 2025;25(1):909.
https://doi.org/10.1186/s12884-025-08083-0.
19.Wang Y, Zhang X, Zheng X, Song G, Fang L, Wang Y, Wang B. Human cytomegalovirus infection and its association with gestational diabetes mellitus during pregnancy. Peer J. 2022;10:e12934.
https://doi.org/10.7717/peerj.12934
20. Megli CJ, Coyne CB. Infections at the maternal-fetal interface: an overview of pathogenesis and defence. Nat Rev Microbiol. 2022;20(2):67-82
https://doi.org/10.1038/s41579-021-00610-y
21. Leber A.L. Maternal and congenital human cytomegalovirus infection: laboratory testing for detection and diagnosis. J Clin Microbiol. 2024;62(4):e0031323.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Д.В. Зубков, З.О. Майданова , K.T. Шыхалиева, А.Ж. Талгатбек

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
